Literature DB >> 23393144

Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides.

Hege Svean Koksvik1, Kåre Birger Hagen, Erik Rødevand, Petter Mowinckel, Tore K Kvien, Heidi A Zangi.   

Abstract

OBJECTIVE: To study the effect of individual nursing consultations in patients treated with disease-modifying antirheumatic drugs (DMARDs) in a rheumatology outpatient setting.
METHODS: Patients with inflammatory arthritides (IA) who had started with a DMARD regimen 3 months before were randomised to two different follow-up consultation systems: either follow-up by a clinical nurse specialist (CNS) or by a medical doctor (MD) in rheumatology 3, 9 and 21 months after randomisation. The primary outcome was patient satisfaction measured by Leeds Satisfaction Questionnaire (LSQ). Secondary outcomes included coping, disease activity, pain, fatigue, patient's global assessment of disease activity and health related quality of life. Effects at 9 and 21 months were estimated by Least Square means calculated from the final mixed model.
RESULTS: Of 68 patients randomised, 65 patients completed assessments at 21 months. Statistically significant improvements in favour of the CNS group were found in all LSQ subscales (all p values<0.001) and in overall satisfaction at 9 months (adjusted mean between-group difference 0.74, 95% CI -0.96 to -0.52) and at 21 months (-0.69, 96% CI -0.87 to -0.50). Disease activity Score 28 joint count (DAS-28) was improved from baseline to 9 months in both groups and improvement was maintained at 21 months, but without any group difference. No statistically significant between-group differences were found in any of the other secondary outcomes.
CONCLUSIONS: Patients with IA are likely to benefit from nurse consultations in terms of increased satisfaction with care compared with MD consultations and without loss of efficacy in terms of clinical outcomes. The study is registered as a clinical trial at the ClinicalTrials.gov (NCT00403676).

Entities:  

Keywords:  Arthritis; Disease Activity; Health services research; Nursing; Patient perspective

Mesh:

Year:  2013        PMID: 23393144     DOI: 10.1136/annrheumdis-2012-202296

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  Centre characteristics determine ambulatory care and referrals in patients with spondyloarthritis.

Authors:  Mariano Andrés; Francisca Sivera; Sabina Pérez-Vicente; Paloma Vela; Loreto Carmona
Journal:  Rheumatol Int       Date:  2016-08-06       Impact factor: 2.631

2.  Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain.

Authors:  R Lopez-Gonzalez; D Seoane-Mato; S Perez-Vicente; M A Martin-Martinez; F Sanchez-Alonso; L Silva-Fernandez
Journal:  Rheumatol Int       Date:  2016-08-18       Impact factor: 2.631

3.  Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial.

Authors:  Elena Myasoedova; Cynthia S Crowson; Rachel E Giblon; Kathleen McCarthy-Fruin; Daniel E Schaffer; Kerry Wright; Eric L Matteson; John M Davis
Journal:  Clin Rheumatol       Date:  2019-07-01       Impact factor: 2.980

4.  Development of an interdisciplinary early rheumatoid arthritis care pathway.

Authors:  Xenia Gukova; Glen S Hazlewood; Hector Arbillaga; Paul MacMullan; Gabrielle L Zimmermann; Cheryl Barnabe; May Y Choi; Megan R W Barber; Alexandra Charlton; Becky Job; Kelly Osinski; Nicole M S Hartfeld; Marlene W Knott; Paris Pirani; Claire E H Barber
Journal:  BMC Rheumatol       Date:  2022-06-25

Review 5.  Patient Satisfaction and Costs of Multidisciplinary Models of Care in Rheumatology: a Review of the Recent Literature.

Authors:  Jill Hall; K Julia Kaal; Junho Lee; Ross Duncan; Nicole Tsao; Mark Harrison
Journal:  Curr Rheumatol Rep       Date:  2018-03-17       Impact factor: 4.592

Review 6.  Benefit of health education by a training nurse in patients with axial and/or peripheral psoriatic arthritis: A systematic literature review.

Authors:  G Candelas; V Villaverde; S García; M Guerra; M J León; J D Cañete
Journal:  Rheumatol Int       Date:  2016-08-20       Impact factor: 2.631

7.  EULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: an audit of the success of implementation in a rheumatology outpatient clinic.

Authors:  Eirik Ikdahl; Silvia Rollefstad; Inge C Olsen; Tore K Kvien; Inger Johanne Widding Hansen; Dag Magnar Soldal; Glenn Haugeberg; Anne Grete Semb
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

8.  The outcome and cost-effectiveness of nurse-led care in the community for people with rheumatoid arthritis: a non-randomised pragmatic study.

Authors:  Richard A Watts; Janice Mooney; Garry Barton; Alex J MacGregor; Lee Shepstone; Lisa Irvine; David G I Scott
Journal:  BMJ Open       Date:  2015-08-25       Impact factor: 2.692

9.  Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).

Authors:  Maxime Dougados; Martin Soubrier; Elodie Perrodeau; Laure Gossec; Françoise Fayet; Mélanie Gilson; Marie-Hélène Cerato; Sophie Pouplin; René-Marc Flipo; Laurent Chabrefy; Gael Mouterde; Liana Euller-Ziegler; Thierry Schaeverbeke; Bruno Fautrel; Alain Saraux; Isabelle Chary-Valckenaere; Gérard Chales; Emmanuelle Dernis; Pascal Richette; Xavier Mariette; Francis Berenbaum; Jean Sibilia; Philippe Ravaud
Journal:  Ann Rheum Dis       Date:  2014-05-28       Impact factor: 19.103

10.  The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial.

Authors:  Mwidimi Ndosi; Martyn Lewis; Claire Hale; Helen Quinn; Sarah Ryan; Paul Emery; Howard Bird; Jackie Hill
Journal:  Ann Rheum Dis       Date:  2013-08-27       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.